Antimicrobial Resistance (AMR)
The University of Leeds is committed to addressing the growing global challenge of antimicrobial resistance (AMR).
Our AMR research involves researchers from across our faculties in a wide range of disciplines. We work to coordinate, foster and promote these research efforts, with the aim of achieving the greatest impact.
What is AMR?
Antimicrobial agents, such as antibiotics, are our primary means of treating infectious diseases in humans and animals. Unfortunately, these drugs are rapidly becoming less effective, as microbes evolve to resist their effects, a phenomenon referred to as antimicrobial resistance or AMR.
If we don’t address AMR as a matter of urgency, over 300 million people worldwide are predicted to die prematurely by 2050.
Our research spans multiple disciplines in a coordinated effort to tackle AMR, focusing on eight key areas.
Why is antimicrobial resistance an urgent public health issue and how can research tackle it?
Read our Medium article highlighting three very different projects in healthcare settings in China, Pakistan and in communities in Nepal.
Events and activities
WAAW runs from 18 to 24 November 2021. This annual event draws attention to the growing challenge of antimicrobial resistance under the slogan ‘spread awareness, stop resistance’.
On 25 November, join us to hear how to support the generation and sharing of AMR surveillance reports and how to solve the problem of low blood culture utilization in low and middle-income countries.
On 16 November, we will be joined by the Vice-Chancellor and WHO to share our findings from the Global Challenge Research Funded (GCRF) project known as CE4AMR: The One Health Approach.
Connect with AMR at Leeds through our padlet board. Find out what areas people are working in and share your experience and expertise.